0000899243-21-024528.txt : 20210617
0000899243-21-024528.hdr.sgml : 20210617
20210617195437
ACCESSION NUMBER: 0000899243-21-024528
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210615
FILED AS OF DATE: 20210617
DATE AS OF CHANGE: 20210617
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Wanstall Rick
CENTRAL INDEX KEY: 0001771222
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38130
FILM NUMBER: 211026630
MAIL ADDRESS:
STREET 1: C/O AILERON THERAPEUTICS, INC.
STREET 2: 490 ARSENAL WAY
CITY: WATERTOWN
STATE: MA
ZIP: 02472
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AILERON THERAPEUTICS INC
CENTRAL INDEX KEY: 0001420565
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 285 SUMMER STREET
STREET 2: UNIT 101
CITY: BOSTON
STATE: MA
ZIP: 02210
BUSINESS PHONE: 617-995-0900
MAIL ADDRESS:
STREET 1: 285 SUMMER STREET
STREET 2: UNIT 101
CITY: BOSTON
STATE: MA
ZIP: 02210
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-06-15
0
0001420565
AILERON THERAPEUTICS INC
ALRN
0001771222
Wanstall Rick
C/O AILERON THERAPEUTICS, INC.
285 SUMMER STREET, SUITE 101
BOSTON
MA
02210
0
1
0
0
See Remarks
Stock Option (right to buy)
1.29
2021-06-15
4
A
0
600000
0.00
A
2031-06-14
Common Stock
600000
600000
D
This option was granted on June 15, 2021. The shares underlying the option are scheduled to vest as to 25% of the shares on June 15, 2022 and thereafter in equal monthly installments through June 15, 2025.
Chief Financial Officer and Treasurer
/s/ Richard Wanstall
2021-06-17